IQVIA HOLDINGS INC.

IQVSEC EDGAR

Services-Commercial Physical & Biological Research(DE)CIK: 1478242

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$15.0B	$14.4B	$13.9B	$11.4B	$11.1B
Research and Development Expense	—	—	—	—	—
Selling, General and Administrative Expense	$2.1B	$2.1B	$2.0B	$1.8B	$1.7B
Operating Income (Loss)	$2.0B	$1.8B	$1.4B	$731.0M	$777.0M
Interest Expense	$672.0M	$416.0M	$375.0M	$416.0M	$447.0M
Other Nonoperating Income (Expense)	$124.0M	-$33.0M	$130.0M	$65.0M	$37.0M
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	$1.5B	$1.4B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$26.9B	$26.7B	$25.3B	$24.7B	$24.6B
Assets, Current	$5.8B	$5.6B	$5.0B	$4.8B	$5.1B
Cash and Cash Equivalents, at Carrying Value	$1.7B	$1.4B	$1.2B	$1.4B	$1.8B
Liabilities	$20.8B	$20.6B	$19.6B	$18.6B	$18.3B
Liabilities, Current	$7.0B	$6.5B	$5.6B	$5.2B	$4.6B
Long-term Debt	—	—	—	—	—
Accounts Payable, Current	—	—	—	—	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$2.1B	$2.3B	$2.9B	$2.0B	$1.4B
Net Cash Provided by (Used in) Investing Activities	-$1.6B	-$2.0B	-$2.1B	-$796.0M	-$1.2B
Net Cash Provided by (Used in) Financing Activities	-$382.0M	-$329.0M	-$1.2B	-$217.0M	-$276.0M
Payments of Dividends	—	—	—	—	—
Payments for Repurchase of Common Stock	$992.0M	$1.2B	$406.0M	$447.0M	$949.0M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)